| RS2527028635 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2527028830 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2527029241 |
GNPAT
|
Health Risk |
Pathogenic |
— |
| RS2527029264 |
GNPAT
|
Health Risk |
Pathogenic |
— |
| RS2527036464 |
FMN2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 47 |
| RS2527036970 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2527037165 |
GNPAT
|
Health Risk |
Pathogenic |
— |
| RS2527037759 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527038050 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527038818 |
TBCE
|
Health Risk |
Pathogenic |
— |
| RS2527039167 |
TBCE
|
Health Risk |
Pathogenic |
— |
| RS2527041400 |
KCNT2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 57 |
| RS2527044242 |
GNPAT
|
Health Risk |
Likely pathogenic |
— |
| RS2527044274 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2527044284 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2527044406 |
MUC1
|
Health Risk |
Likely pathogenic |
Tubulointerstitial kidney disease, autosomal dominant |
| RS2527044533 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2527044560 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2527044612 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2527047139 |
GNPAT
|
Health Risk |
Likely pathogenic |
Rhizomelic chondrodysplasia punctata type 2, Rhizomelic chondrodysplasia punctata type 2 |
| RS2527047592 |
HUWE1
|
Health Risk |
Likely pathogenic |
HUWE1-related disorder, HUWE1-related disorder |
| RS2527047768 |
GNPAT
|
Health Risk |
Pathogenic |
— |
| RS2527048870 |
HUWE1
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked syndromic |
| RS2527049898 |
MUC1
|
Health Risk |
Likely pathogenic |
Tubulointerstitial kidney disease, autosomal dominant |
| RS2527051551 |
TBCE
|
Health Risk |
Pathogenic |
— |
| RS2527070597 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527071591 |
TBCE
|
Health Risk |
Pathogenic |
— |
| RS2527071646 |
TBCE
|
Health Risk |
Pathogenic |
— |
| RS2527072205 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527072900 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527078373 |
TBCE
|
Health Risk |
Pathogenic |
— |
| RS2527078803 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527080172 |
LYST
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2527080870 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527081103 |
LYST
|
Health Risk |
Likely pathogenic |
LYST-related disorder, LYST-related disorder |
| RS2527086071 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527086097 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527087129 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527100064 |
ST3GAL3
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2527102709 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527103588 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527105833 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527106533 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527109083 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527110492 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, LYST-related disorder |
| RS2527113160 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527113303 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527113758 |
KCNT2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 57 |
| RS2527114176 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527114523 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527115755 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527115993 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527116390 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527119870 |
BCL10
|
Health Risk |
Pathogenic |
Immunodeficiency 37, Immunodeficiency 37 |
| RS2527120727 |
KCNH1
|
Health Risk |
Conflicting classifications of pathogenicity |
KCNH1 associated disorder, KCNH1 associated disorder |
| RS2527120758 |
KCNH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Zimmermann-Laband syndrome 1, Zimmermann-Laband syndrome 1 |
| RS2527120778 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527120913 |
KCNH1
|
Health Risk |
Pathogenic |
— |
| RS2527121232 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527121662 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527122347 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527122910 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527128643 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527133215 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527146010 |
ASH1L
|
Health Risk |
Pathogenic |
— |
| RS2527146722 |
F13B
|
Health Risk |
Likely pathogenic |
F13B-related disorder, F13B-related disorder |
| RS2527148458 |
B3GALNT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS2527151935 |
ASH1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS2527154062 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527158994 |
ASH1L
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2527159983 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527159996 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527167934 |
B3GALNT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS2527171863 |
ASH1L
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS2527176109 |
ASH1L
|
Health Risk |
Likely pathogenic |
— |
| RS2527185382 |
ASH1L
|
Health Risk |
Pathogenic |
— |
| RS2527187534 |
ASH1L
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2527187941 |
ASH1L
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS2527188107 |
ASH1L
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS2527200635 |
B3GALNT2
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS2527209619 |
FBXO28
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 100, Developmental and epileptic encephalopathy 100 |
| RS2527210283 |
KIF14
|
Health Risk |
Likely pathogenic |
Microcephaly 20, primary |
| RS2527210571 |
ASH1L
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 52 |
| RS2527215447 |
CR2
|
Health Risk |
Likely pathogenic |
Systemic lupus erythematosus, susceptibility to |
| RS2527218073 |
CR2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS2527219225 |
CR2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS2527222545 |
CR2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS2527223934 |
CR2
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS2527224555 |
CR2
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS2527225441 |
CR2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS2527246387 |
UBAP2L
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with impaired language, behavioral abnormalities |
| RS2527247243 |
UBAP2L
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with impaired language, behavioral abnormalities |
| RS2527252200 |
CR2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS2527257698 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527257999 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527258082 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527258499 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527258815 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527259540 |
DEGS1
|
Health Risk |
Likely pathogenic |
Leukodystrophy, hypomyelinating |
| RS2527259690 |
DEGS1
|
Health Risk |
Pathogenic |
— |